DPM 1, 2 or 3
Showing 1 - 25 of >10,000
Diabetes Trial in Seongnam-si (BR3006-1, BR3006-2, BR3006-3)
Not yet recruiting
- Diabetes Mellitus
- BR3006-1
- +2 more
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofCHA Bundang Medical Center(CBMC)
Jul 17, 2023
Diabetes, Type 2, Diabetes, Type 1, Gastroparesis With Diabetes Trial in Cleveland (FreeStyle Libre 3 continuous glucose
Not yet recruiting
- Diabetes Mellitus, Type 2
- +2 more
- FreeStyle Libre 3 continuous glucose monitoring sensor
-
Cleveland, OhioCleveland Clinic Foundation
Sep 6, 2023
Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),
Not yet recruiting
- Poliomyelitis
- Novel oral poliomyelitis vaccine type 1 (nOPV1)
- +3 more
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research
Nov 14, 2023
Stroke, Acute Trial in Karachi (Sodium Chloride 0.9% infusion alone or in combination with Sodim acetate with normal saline in a
Recruiting
- Stroke, Acute
- Sodium Chloride 0.9% infusion alone or in combination with Sodim acetate with normal saline in a ratio 1;1, 2;1 and 3;1
-
Karachi, PakistanAga Khan University
May 19, 2023
COVID-19 Trial in Newport Beach (hAd5-S-Fusion+N-ETSD, Placebo (0.9% (w/v) saline))
Completed
- COVID-19
- hAd5-S-Fusion+N-ETSD
- Placebo (0.9% (w/v) saline)
-
Newport Beach, CaliforniaHoag Memorial Hospital Presbyterian
Sep 1, 2023
Hypertension, Diabetes, Type 2 Trial in Incheon (BR1019-1, BR1019-2, BR1019-1 + BR1019-2)
Recruiting
- Hypertension
- Diabetes Mellitus, Type 2
- BR1019-1
- +2 more
-
Incheon, Korea, Republic ofInha University Hospital
May 16, 2023
Consumer Behavior, Food Selection Trial in Ghent (The intervention "Aan Tafel in 1, 2, 3 euro")
Recruiting
- Consumer Behavior
- Food Selection
- The intervention "Aan Tafel in 1, 2, 3 euro"
-
Ghent, BelgiumGhent University
Dec 20, 2022
Solid Tumor Trial (BS006 Injection)
Not yet recruiting
- Solid Tumor
- BS006 Injection
- (no location specified)
Jul 3, 2023
Esophageal Squamous Carcinoma, HER-2 Protein Overexpression Trial (RC48+PD-1+platinum-based)
Not yet recruiting
- Esophageal Squamous Carcinoma
- HER-2 Protein Overexpression
- (no location specified)
Sep 24, 2023
COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))
Not yet recruiting
- COVID-19
- NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
- Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
- (no location specified)
Aug 4, 2023
Febrile Illness Trial (Connex CSVM with Timmy3 module)
Not yet recruiting
- Febrile Illness
- Connex CSVM with Timmy3 module
- (no location specified)
Sep 25, 2023
Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (2 cycles induction chemo, 3 cycles induction chemo)
Recruiting
- Locally Advanced Nasopharyngeal Carcinoma
- 2 cycles induction chemotherapy
- 3 cycles induction chemotherapy
-
Guangzhou, Other (Non U.s.), ChinaFirst Affiliated Hospital, Sun Yat-Sen University
May 6, 2023
Long QT Syndrome Trial in West Bend (LQT-1213, Placebo, Dofetilide 250 µg Cap)
Active, not recruiting
- Long QT Syndrome
- LQT-1213
- +2 more
-
West Bend, WisconsinSpaulding Clinical Research, LLC
Jun 15, 2023
Nicotine Use Disorder Trial (E-liquid coolant (no WS-3) (1), E-liquid coolant (Low WS-3) (1), E-liquid coolant (High WS-3) (1))
Not yet recruiting
- Nicotine Use Disorder
- E-liquid coolant (no WS-3) (1)
- +8 more
- (no location specified)
Jul 7, 2023
Glaucoma, Primary Open Angle, Ocular Hypertension Trial in Newport Beach (Study Treatment 1 WB007, Study Treatment 2 WB007,
Active, not recruiting
- Glaucoma, Primary Open Angle
- Ocular Hypertension
- Study Treatment 1 WB007
- +3 more
-
Newport Beach, CaliforniaEye Research Foundation
Dec 30, 2022
Influenza, Human Trial (Investigational aQIVc, licensed QIV1, licensed QIV2)
Not yet recruiting
- Influenza, Human
- Investigational aQIVc
- +2 more
- (no location specified)
Aug 28, 2023
Treatment of Symptoms of Grade 2 and Grade 3 Late Xerostomia From Salivary Gland Hypofunction Caused by Radiotherapy for Cancer
Recruiting
- Treatment of Symptoms of Grade 2 and Grade 3 Late Xerostomia From Salivary Gland Hypofunction Caused by Radiotherapy for Cancer of the Oropharynx
- AAV2-hAQP1 Concentration 1
- +2 more
-
Charlotte, North CarolinaAtrium Health
Jun 22, 2023
Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)
Not yet recruiting
- Diabetes Mellitus Type 2 With Proteinuria
- +12 more
- Empagliflozin 10 MG
- +6 more
- (no location specified)
Oct 17, 2023
Hiv Trial in Amsterdam (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage)
Not yet recruiting
- Hiv
- BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage
-
Amsterdam, NetherlandsThe Amsterdam University Medical Centers
Aug 2, 2023
Healthy Volunteers, Type 2 Diabetes Trial in Overland Park (Semaglutide D Dose 1, Semaglutide D Dose 2, Semaglutide D Dose 3)
Active, not recruiting
- Healthy Volunteers
- Type 2 Diabetes
- Semaglutide D Dose 1
- +5 more
-
Cypress, California
- +2 more
Dec 27, 2022
Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)
Not yet recruiting
- Triple Negative Breast Cancer
- Proleukin 1.3 MG Injection
- (no location specified)
Apr 6, 2023
Metastatic Solid Tumor Trial (TAC01-CLDN18.2)
Not yet recruiting
- Metastatic Solid Tumor
- TAC01-CLDN18.2
- (no location specified)
May 8, 2023
Elbow Fracture, Elbow Injury, Elbow Dislocation Trial in Canada, United States (Lactose Placebo, Ketotifen Fumarate 2mg,
Recruiting
- Elbow Fracture
- +2 more
- Lactose Placebo
- +2 more
-
Baltimore, Maryland
- +16 more
Dec 8, 2022